SCHEMBL5369248

SCHEMBL5369248

O=C1Nc2ccc(CCCl)cc2C1=Cc1ccc(Br)o1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 3/20 0.65
RPS6KA3 P51812 3/20 0.46
PTPN1 P18031 5/20 0.43
PTPN2 P17706 2/20 0.43
POLB P06746 3/20 0.43
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
DYRK1A Q13627 1/20 0.43
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
ALOX12 P18054 1/20 0.43
MAPT P10636 2/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
RECQL P46063 1/20 0.42
MCL1 Q07820 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
PDPK1 O15530 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5367282 0.86 KMT2A (0.60) RETRPS6KA3PTPN1PTPN2POLB
SCHEMBL5363472 0.84 PTPN1 (0.48) RETRPS6KA3PTPN1PTPN2POLB
SCHEMBL7134047 0.84 PTPN1 (0.48) RETRPS6KA3PTPN1PTPN2POLB
SCHEMBL5357851 0.82 RET (0.53) RETRPS6KA3PTPN1PTPN2POLB
SCHEMBL702178 0.82 RET (0.73) RETRPS6KA3PTPN1PTPN2PSEN1
SCHEMBL702179 0.82 RET (0.73) RETRPS6KA3PTPN1PTPN2PSEN1
SCHEMBL5366390 0.81 ALDH1A1 (0.45) RETRPS6KA3PTPN1POLBALDH1A1
SCHEMBL5367384 0.79 RPS6KA3 (0.43) RETRPS6KA3PTPN1POLBALDH1A1
SCHEMBL5358302 0.77 MEN1 (0.49) RETRPS6KA3POLBMEN1KMT2A
SCHEMBL7139731 0.77 RET (0.42) RETRPS6KA3POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK RET 283/4885RPS6KA3 271/4885PTPN1 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.